Palm Beach physician pioneering new advances in ALS and inflammatory disease treatment
Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to accelerate the clinical development of "T regulatory cell" therapies for the treatment of autoimmune diseases and inflammatory disorders.
T regulatory cells, or Tregs (pronounced tee-regs), are natural immune system regulator cells that suppress the activity of other immune cells to prevent excessive inflammation and autoimmune reactions.
Before launching Cellenkos, Parmar conducted extensive research on these cells and developed therapies based on them.
While working as an oncologist/hematologist in the Department of Stem Cell Transplantation and Cellular Therapy at the University of Texas's MD Anderson Cancer in Houston in 2009, she developed treatments using T regulatory cells derived from umbilical cord blood to help prevent graft-versus-host disease (GVHD), a complication that can occur after an allogeneic stem cell or bone marrow transplant.
Parmar told the Daily News it was 'very discouraging' to watch patients die from GVHD, which motivated her to focus her research on controlling the inflammation caused by donor cells, starting with the discovery of T regulatory cells. As she continued to conduct her research, she discovered that these cells had uses beyond preventing GVHD.
"We found that the application of these cells is beyond just that one niche," she told the Daily News. "It can be applied to any autoimmune disease, to any inflammatory disorder."
In 2016, the cell technology Parmar developed at MD Anderson was licensed to Cellenkos, which now supports her ongoing research through a sponsored research agreement.
Since then, Parmar has focused on her work advancing targeted Treg cell therapies designed to ease inflammation and regulate immune function.
Cellenkos is currently in clinical trials for various inflammatory and autoimmune diseases, including ALS, bone marrow failure, severe COVID-19 and myelofibrosis. Results have been positive so far, Parmar said, noting that ALS patients have seen a delay in disease progression and functional decline and an improvement in quality of life.
"We have made some great strides in neurodegenerative disease," she said. "We just published a paper in the New England Journal of Medicine Evidence on ALS, where we showed not only disease halting, but slight improvement in resolving inflammation. That research has applications beyond just ALS. We are hoping as we are garnering more funding, we can go after Parkinson's, Alzheimer's and multiple sclerosis."
Inflammation is the root cause of many diseases including cardiac, respiratory, neurological and hematological disorders, Parmar said, and it also drives many autoimmune diseases.
Parmar's cell therapies restore immune balance by targeting harmful T cells — a type of white blood cell called lymphocytes — that can mistakenly attack healthy cells in the body, and retraining the body's own defense mechanisms.
"We have a drug that heals inside out," she said. "We believe that we neutralize the bad player, which may not have initiated the inflammation, but definitely plays a key role in the propagation of widespread inflammation."
Parmar, a mother of three who lives in Palm Beach's North End and travels regularly to Houston, where Cellenkos is based, said she remains committed to developing cell therapies targeting a broad range of autoimmune and inflammatory diseases.
Cellenkos is pursuing funding for larger ALS research studies in the U.S., and it is also preparing for the next phase of clinical trials required for federal Food and Drug Administration approval.
Parmar said she sees Palm Beach County's emergence as a neuroscience hub as a key benefit of her move, and she hopes it will lead to new research, development, and partnership opportunities.
"We're incredibly excited about the momentum building in the Palm Beach and Jupiter area around neuroscience innovation," she said. "With new opportunities for R&D collaboration in the region, it presents an ideal environment for us to expand. We see great potential not only to develop a manufacturing facility for neurological compounds … but also to establish a dedicated treatment center that brings these breakthroughs directly to patients.'
Jodie Wagner is a journalist at the Palm Beach Daily News, part of the USA TODAY Florida Network. You can reach her at jwagner@pbdailynews.com.
This article originally appeared on Palm Beach Daily News: Palm Beach physician-scientist pioneering groundbreaking ALS therapy
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
18 minutes ago
- Medscape
Start With the Why: Easing Fears of Cardiac Testing
It's common for patients to schedule an office visit due to symptoms like shortness of breath from doing regular tasks, feeling heart palpitations, experiencing mild chest pain, or feeling weak or unusually tired. During your assessment, if you determine that the patient has an irregular heartbeat, a family history of cardiac conditions, or believe further testing is warranted, realize that a patient could be fearful of cardiac testing. To ease the concerns of your patients, it's important to explain how such testing can diagnose the reason they aren't feeling quite right and how their treatment team can help them feel better. Start With the Why Leaving the trusted environment of a primary care office can be daunting for patients, particularly for those who haven't had cardiac testing before. But explaining why you're suggesting the tests can help a patient understand. "The most important step would be to explain how cardiac testing can be important in order to screen for issues before they become serious," said David Weininger Cohen, MD, a cardiologist with the Leonard M. Miller School of Medicine at the University of Miami in Florida. He also suggested recounting what symptoms patients are experiencing and how specific tests can investigate what's causing them. Also, explaining that some symptoms may not even be tied to cardiac issues could be another strategy to demonstrate the importance of further testing. "For instance, chest pain is a symptom that becomes a common reason for visits. Most people usually associate chest pain with heart issues, but there are a lot of structures in the chest that can cause pain, not just the heart — cartilage, esophagus, sometimes part of the stomach, skin, and even nerve endings," he said. "Ultimately, cardiac testing is important because it allows the physician to discriminate between cardiac and non-cardiac causes for the patient's symptoms." In addition, reassuring your patients that these experts can diagnose potential issues may also ease their worries, so articulate how such cardiac tests are performed in a controlled environment with trained staff that can anticipate issues and respond quickly if something goes wrong, Weininger Cohen added. Understand Patients Are Fearful of Test Results Some patients are afraid of the results as much as the test. "In those cases, I like to reinforce why the test is necessary and why we're doing it," said Weininger Cohen. "Additionally, I sometimes go through the possible scenarios depending on the results of each test." Knowing what lies ahead, depending on what the test shows, can sometimes be reassuring — you're showing patients you know exactly what the next steps would be. Treat Fears Patient by Patient Although there are some general practice strategies to ease fear regarding cardiac testing, personalizing your approach is also important. "The best way to tackle fear of cardiac testing would be to ask the patient exactly what they're afraid of," said Weininger Cohen. Some patients are going to be afraid of having pain or discomfort during the test. Some patients are afraid of what the results may be, and some patients are afraid of possible complications. "Usually, the best way to approach the topic is to explain the reason for the test and then address the specific fear the patient has," he specified. For example, the best way to describe an EKG would be to explain that it is a test that is trying to capture the electrical activity of the heart. To achieve that, the person performing it is putting sensors on different parts of the patient's body to detect the heart's electrical current from different points, he said. Emphasizing that the test is painless, and that it's just capturing the natural electrical activity of the heart, should put patients at ease. How Can You Best Describe an Echocardiogram? Most patients understand what an ultrasound is, so advising patients that an echocardiogram is simply an ultrasound study of the heart can calm fears. It may also be helpful to share that in some cases, ultrasounds use enhancing agents, referred to as contrast, to get a look at the different structures of the heart, he said. Some patients could be concerned about radiation. "Both tests are radiation free, and this is something that some patients are very interested in knowing before proceeding, especially if they have been previously exposed to radiation through other diagnostic imaging tests or radiotherapy for cancer treatment," Weininger Cohen said. Taking the time to explain both an echocardiogram and an EKG can help your patients understand what to expect and reduce worry and the fear of the unknown. What to Tell Patients Before Referring to a Cardiologist Referring a patient to a specialist like a cardiologist could cause fear. So explain why you're taking this step. Mustafa M. Ahmed, MD "Telling a patient why they need to see a heart expert and how they will add to their overall care can be a helpful first step," said Mustafa M. Ahmed, MD, a cardiologist and professor of medicine, who's also vice chief of research of the Division of Cardiovascular Medicine and medical director of the Mechanical Circulatory Support Program at the University of Florida in Gainesville. "Assuring them that they won't be losing their primary care doctor, but gaining a specialist to consult with both them and the primary care team, is often a good way to frame expectations." Lifestyle Tweaks You Might Suggest In the context of your discussions with patients regarding their symptoms and recommendations for cardiac testing, Ahmed suggested expressing how diet and exercise, as a part of overall lifestyle changes, can be the most impactful way to prevent heart disease. "Gentle guidance and step-by-step encouragement are often helpful," he said. Also, involving other family members and friends in that journey is another strategy. This may include taking walks, preparing meals together, or embracing a healthier mindset overall.
Yahoo
34 minutes ago
- Yahoo
Doctors and public health organizations sue Kennedy over vaccine policy changes
NEW YORK (AP) — A coalition of doctors groups and public health organizations sued the U.S. government on Monday over the decision to stop recommending COVID-19 vaccinations for most children and pregnant women. The American Academy of Pediatrics, American Public Health Association and four other groups — along with an unnamed pregnant doctor who works in a hospital — filed the lawsuit in federal court in Boston. U.S. health officials, following infectious disease experts' guidance, previously urged annual COVID-19 shots for all Americans ages 6 months and older. But in late May, Health Secretary Robert F. Kennedy Jr. announced he was removing COVID-19 shots from the Centers for Disease Control and Prevention's recommendations for healthy children and pregnant women. A number of health experts decried the move as confusing and accused Kennedy of disregarding the scientific review process that has been in place for decades — in which experts publicly review current medical evidence and hash out the pros and cons of policy changes. The new lawsuit repeats those concerns, alleging that Kennedy and other political appointees at the U.S. Department of Health and Human Services have flouted federal procedures and systematically attempted to mislead the public. 'This administration is an existential threat to vaccination in America, and those in charge are only just getting started,' said Richard H. Hughes IV, the lead attorney for the plaintiffs. 'If left unchecked, Secretary Kennedy will accomplish his goal of ridding the United States of vaccines, which would unleash a wave of preventable harm on our nation's children.' HHS officials did not immediately respond to a request for comment. Also joining the suit are the American College of Physicians, the Infectious Diseases Society of America, the Massachusetts Public Health Association and the Society for Maternal-Fetal Medicine. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Geek Tyrant
38 minutes ago
- Geek Tyrant
SAPCEBALLS 3 Is Reportedly in Development After SPACEBALLS 2 Announcement — GeekTyrant
The Schwartz may be growing stronger than we thought. While Spaceballs 2 is still on track for its 2027 theatrical debut, a new rumor suggests Amazon MGM Studios is already quietly moving ahead with Spaceballs 3 . The report came from trusted scooper MyTimeToShineHello, who posted on X, 'MGM already developing a SPACEBALLS 3.' No official confirmation from Amazon just yet, but if true, this signals that the long-dormant parody franchise is being set up for a full-on revival. We might be getting a Spaceballs trilogy. This rumor drops just weeks after solid details emerged about Spaceballs 2 , which is being pitched as a 'Non-Prequel Non-Reboot Sequel Part Two but with Reboot Elements Franchise Expansion Film.' The cast of Spaceballs 2 is shaping up to be a mix of legacy and new blood. Bill Pullman is returning as Lone Starr. Rick Moranis is back in the oversized helmet as Dark Helmet. Mel Brooks is also returning as Yogurt. They'll be joined by newcomers Keke Palmer and Lewis Pullman as Lone Starr's son. Josh Greenbaum ( Barb and Star Go to Vista Del Mar ) is directing, with a script from Detective Pikachu writers Benji Samit and Dan Hernandez, along with Josh Gad, who's also starring and producing. The film's producing team includes Brian Grazer, Ron Howard, Jeb Brody, Greenbaum, and Mel Brooks, with executive producers Kevin Salter, Adam Merims, Samit, and Hernandez. The original Spaceballs launched in 1987 as a loving (and ridiculous) spoof of Star Wars , 2001: A Space Odyssey , and other classic sci-fi. It was met with a lukewarm critical reception but carved out cult status, thanks to its absurd humor, great characters, and quotable lines. So, is Spaceballs 3 really in motion before Part 2 even hits theaters? It's still just a rumor, but the idea of Amazon MGM Studios going all-in on the franchise makes sense. There's nostalgia, name recognition, and a perfect moment to poke fun at modern IP-obsessed Hollywood.
